Naldemedine-induced Opioid Withdrawal Syndrome in a Patient with Breast Cancer without Brain Metastasis-Reference-Cited by-同舟云学术

Naldemedine-induced Opioid Withdrawal Syndrome in a Patient with Breast Cancer without Brain Metastasis

Published:2020-01-15 Issue:2 Volume:59 Page:293-296
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Ishii Koji¹²,Yamashita Haruna¹²,Yamaguchi Midori¹,Komatsu Yuya¹,Ryu Emi²³,Morishita Satoru²⁴,Matsuo Kumi²⁴,Kamada Masatsugu²⁵,Ikeda Tsunako²⁴,Ashizawa Kazuto²⁵,Hara Tetsuya¹

Affiliation:

1. Department of Anesthesiology, Nagasaki University School of Medicine, Japan

2. Palliative Center, Nagasaki University Hospital, Japan

3. Department of Hospital Pharmacy, Nagasaki University Hospital, Japan

4. Department of Nursing, Nagasaki University Hospital, Japan

5. Department of Clinical Oncology, Nagasaki University Graduate School of Biomedical Science, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/59/2/59_3098-19/_pdf

Reference9 articles.

1. 1. Wesson DR, Ling W. The Clinical Opiate Withdrawal Score (COWS). J Psychoactive Drugs 35: 253-259, 2003.

2. 2. Mearin F, Lacy BE, Chang L, et al. Bowel disorders. Gastroenterology 150: 1393-1407, 2016.

3. 3. Katakami N, Harada T, Murata T, et al. Randomized phase III and extension studies on naldemedine in patients in opioid-induced constipation and cancer. J Clin Oncol 3: 3859-3866, 2017.

4. 4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed (DSM-5). American Psychiatric Association, Arlington, 2013.

5. 5. Candy B, Jones L, Vickerstaff V, et al. Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care. Cochrane Database Syst Rev 6: CD006332, 2018.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Naldemedine-induced opioid withdrawal with restlessness as the predominant symptom in a palliative care setting;Palliative and Supportive Care;2023-06-23

2. Naldemedine versus placebo in opioid-induced constipation: a meta-analysis;BMJ Supportive & Palliative Care;2022-12-14

3. Opioid withdrawal symptoms after neurolytic splanchnic nerve block in cancer patients;Supportive Care in Cancer;2022-12-14

4. Factors associated with non-response to naldemedine for opioid-induced constipation in cancer patients: A subgroup analysis;PLOS ONE;2022-12-09

5. Opioid withdrawal syndrome developing after long-term administration of naldemedine;Palliative and Supportive Care;2022-05-11